EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Heterozygous RNF13 Truncating Variants Are Associated With Developmental and Epileptic Encephalopathy

Donald R. Latner, Susan M. Hiatt, Candice R. Finnila, Whitley V. Kelley, Marla Johnston, Jessica Patrick‐Esteve, Nour Elkhateeb, Mona A. Kamel, Tahsin Stefan Barakat, Marjon van Slegtenhorst, Martin A. Mensah, Lewis Pang, Pamela Bowman, Henrietta Lefroy, Ruth Cleaver, Rachel Palmquist, Amanda G. Sandoval Karamian, Emma E. Smith, Suha Bachir, Kristin G. Monaghan, Ingrid M. Wentzensen, Cathy A. Stevens, Jill Pouncey, Elizabeth Fieg, Joel B. Krier, Claudio Melo de Gusmao, J. Carl Pallais, Peter T. Skidmore, Pritha Bisarad, Somayeh Bakhtiari, Michael C. Kruer, Guillermo Philipps, Mostafa Asadollahi, Mohammad Keramatipour, Xavier Blanc, Emmanuelle Ranza, Christian M. Korff, Jeffrey W. Innis, Greg M. Cooper, Stylianos E. Antonarakis

American Journal of Medical Genetics Part A · 2026-12 · 200 (12) · 2649-2655

DOI: 10.1002/ajmg.a.70241 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Developmental and epileptic encephalopathy 73 (DEE73; OMIM 618379) is an autosomal dominant severe neurodevelopmental disorder associated with pathogenic variants in the RING finger protein 13 gene (RNF13; OMIM 609247), which encodes a transmembrane E3 ubiquitin ligase. The phenotype of affected individuals includes microcephaly, seizures, intellectual disability, developmental delay, absent or limited speech, restricted movement, cortical blindness, and skeletal defects (hip dysplasia, club feet, scoliosis). The currently known DEE73 phenotype is based on two reports of four unrelated individuals: three with missense variants in a di‐leucine motif that is essential for binding to the Adaptor Protein Complex 3 (AP‐3), and one with a truncating variant located in the last exon. This case series of an additional 13 affected individuals with RNF13 variants (2 missense, 11 truncating) supports and broadens previous reports. Importantly, it helps to define a narrow but critical region of the protein that is intolerant to truncating variation, although the gene is not highly constrained.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →